Tags

Journalists: Please sign up for PEERmedia to receive all our recent releases, documents and other information that affect not only public employees, but the public at large.


Ethics Experts Explain How to Protect Taxpayers From Pruitt-Like Scandals

From: Think Progress

"Among its more than a dozen recommendations, the OIG says the EPA should recover these funds from the “responsible official or officials.” Ten of the 14 recommendations…

Wallace Could Fill Extended Interior Vacancy

From: Jackson Hole News & Guide

"If confirmed, in fact, Wallace would oversee two agencies that have lacked Senate-confirmed leadership dating to when Trump took office. Dan Smith,…

Parents, Schools Await Results of Federal Health Study into Synthetic Turf with Tire Crumbs

From: The Oregonian

"This delay was entirely predictable based on the history of this issue particularly and of the current administration’s languid stance on health and safety,” he…

Toothless Law Lets White House Keep Jobs Vacant

From: E&E News

"More than halfway through President Trump's first term, the Interior Department remains rife with key vacancies despite a federal law that suggests the agency should…

PEER Challenges Legality of NPS Operations Deputy Appointment

From: Federal News Network

"PEER said David Vela can’t legally serve as the National Park Service’s acting deputy director for operations because he was appointed by another deputy…


News Releases

MOST U.S. WATERS ARE POLLUTED AND GETTING DIRTIER

EPA Figures Show Grim Pollution Realities on 40th Anniversary of Clean Water Act

JUDGE HALTS GE CROPS ON SOUTHEASTERN WILDLIFE REFUGES

Separate Ruling Leaves Door Ajar for GE Crops on Midwestern Refuges for Now

YELLOWSTONE’S NEW CELL TOWER PRE-APPROVED DESPITE IMPACTS

Disingenuous Call for Public Comments Does Not Cure Violations of Law and Policy

INVESTIGATION FAILS TO SORT OUT WEATHER SERVICE FISCAL SCANDAL

NOAA Casts Blame but Cannot Find Cause for Massive Budgetary Check Kiting

VOLUNTARY LIVESTOCK DRUG WITHDRAWAL PROSPECTS ILLUSORY

FDA Wishful Strategy of Corporate Cooperation to Stem Growing Drug Resistance